PTGS2 and cancer: Nonetheless, aspirin could also elicit anti-tumor effects in these cancer entities via downregulation of COX-2 mRNA expression (potentially via the salicylate moiety of the drug) and a shift in COX-2 enzymatic activity (acetylation by aspirin).